Agreed, CR's are a normal part of business for companies like this. That said given these results I would think a CR would be well oversubscribed to long term holders wanting to get a big piece so wont cause too many issues.
- Forums
- ASX - By Stock
- IIQ
- Ann: Outstanding SubB2M Ovarian Cancer Test Data
IIQ
inoviq ltd
Add to My Watchlist
2.70%
!
38.0¢

Ann: Outstanding SubB2M Ovarian Cancer Test Data, page-369
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
38.0¢ |
Change
0.010(2.70%) |
Mkt cap ! $42.42M |
Open | High | Low | Value | Volume |
37.5¢ | 38.0¢ | 37.0¢ | $30.30K | 81.18K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 13072 | 37.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
38.0¢ | 3228 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 13072 | 0.370 |
3 | 29865 | 0.365 |
5 | 134100 | 0.360 |
1 | 14076 | 0.355 |
11 | 79374 | 0.350 |
Price($) | Vol. | No. |
---|---|---|
0.380 | 3228 | 2 |
0.385 | 21085 | 3 |
0.390 | 27467 | 3 |
0.400 | 167 | 1 |
0.405 | 10000 | 1 |
Last trade - 10.58am 22/07/2025 (20 minute delay) ? |
Featured News
IIQ (ASX) Chart |